In each model, shRNA‐mediated inhibition of aberrant ERK signaling promotes bypass of senescence allowing tumor formation in vivo, consistent with prior studies (Supporting Information Figure S3) (Deschenes‐Simard et al., 2013). The gene discussed is MAPK1; the disease is neoplasm.